The effect of fixation and processing on the sensitivity of oestrogen receptor assay by immunohistochemistry in breast carcinoma.
暂无分享,去创建一个
[1] I. Ellis,et al. Delay to fixation of invasive breast carcinoma: Effect on mitotic count, MIB1, ER and P53 expression , 2001 .
[2] D. Barnes,et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems , 2000, Journal of clinical pathology.
[3] D. Tripathy,et al. Tamoxifen for early breast cancer: An overview of the randomised trials , 1999 .
[4] L. Beex,et al. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. , 1998, European journal of cancer.
[5] D. Barnes,et al. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. , 1996, British Journal of Cancer.
[6] J. Feldman,et al. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol‐based ligand‐binding assays , 1996, Cancer.